Vaccitech
7 known investors
Find your way into Vaccitech
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that direct T cells to address autoimmune and inflammatory diseases. Its work targets immunology and inflammatory (I&I) indications for patients.
Investors · 7
How we know: Future Planet Capital's portfolio page · funding news · futureplanetcapital.com · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · Not right? Tell us
How we know: funding news · futureplanetcapital.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$168M disclosed across 1 round · 2021
- $168MSeries BMar 2021 · 4 sources
M&G Investment Management (lead), Future Planet Capital, Gilead Sciences, Monaco Constitutional Reserve Fund, Oxford Sciences Innovation, Tencent
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Vaccitech do?
- Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing immunotherapies that direct T cells to address autoimmune and inflammatory diseases. Its work targets immunology and inflammatory (I&I) indications for patients.
- Who are Vaccitech's investors?
- Vaccitech's investors include Future Planet Capital, GV (Google Ventures), Gilead Sciences.
- How much funding has Vaccitech raised?
- Vaccitech has disclosed $168M raised across 1 round.